The ALCEDIAG Scientific Board provides strategic, scientific and technical guidance and direction for the company. The Board is composed of leading experts in their field, with rich, varied, geographically diverse and complementary experiences.
Experts on the Scientific Board and ALCEDIAG team members share strong human values and one ambition: making a change in mental illness diagnosis and management.
Professor Courtet is Professor of psychiatry at the University of Montpellier, and Head of the Department of Emergency & Post-acute care Psychiatry at the Academic Hospital, Montpellier, France. He leads the “vulnerability of suicidal behavior” research group at INSERM (French national institute for health and medical research) Unit 1061.
Professor Courtet obtained his PhD in Neuroscience in “the genetics of suicidal behavior”. His areas of interest and expertise involve vulnerability to suicidal behavior, particularly focusing on brain imaging and the role of social pain in suicidal behaviors. He is now implementing m-health projects using web-based tools for assessing and managing suicidal patients.
Professor Courtet is Chairman of the “suicide” task force at the World Federation of Societies of Biological Psychiatry and is currently the President of the French Association of Biological Psychiatry and Neuropsychopharmacology. He is also a member of the European Psychiatric Association and the European College of Neuropsychopharmacology.
He has published around 200 articles in peer-reviewed journals and numerous chapters. He has also edited three books on suicidal behavior and received the WFSBP Award of Excellence in Education.
Professor Gorwood is a full Professor of Psychiatry at Paris Sainte-Anne Hospital and Head of the Mental and Brain Illnesses Clinic department. In addition, he is head of the INSERM (French national institute for health and medical research) research unit team dedicated to genetic vulnerability of psychiatric and addictive disorders.
Professor Gorwood has published over 240 scientific articles and contributed to the writing of more than 20 books. He is editor-in-chief of the European Psychiatry journal and has served on 16 editorial boards for journals in psychiatry, neuroscience and genetics.
Professor Gorwood is an active member of the European Psychiatric Association for which he acts as treasurer and is member of the Core Organizing and Scientific Committee, of the Executive Committee and of the board. In 2009, he joined the scientific advisory board of the European College of Neuropsychopharmacology for addictive disorders and is the Vice-President of the Federation for Research on Alcohol.
Notably, Professor Gorwood has received the ‘best research’ award from the French National Academy of Medicine.
Professor Kupfer, is a Distinguished Professor Emeritus of Psychiatry at the University of Pittsburgh School of Medicine and held the position of Thomas Detre Professor in Psychiatry from 1994 to 2014.
Between 1983 and 2009, Professor Kupfer served as Chair of the Department of Psychiatry at the University of Pittsburgh School of Medicine, and Director of Research at Western Psychiatric Institute and Clinic. Under his direction, WPIC became one of the nation's foremost university-based psychiatric research centers.
A prolific writer, Professor Kupfer has authored or co-authored more than 1,120 articles, books, and chapters. Professor Kupfer's own research has focused primarily on long-term treatment strategies for recurrent mood disorders, the pathogenesis of depression, and the relationship between biomarkers and depression.
He is the Founding President of the International Society of Bipolar Disorders. From 2008 to its publication in 2013, Professor Kupfer chaired the American Psychiatric Association Task Force for DSM-5.
In 1990, he was elected to the National Academy of Medicine (formerly the Institute of Medicine).
Professor Langer has been Full Professor of Medicinal Psychiatry at University of Vienna since 2013, where he is head of the Department of Pharmaceutical Chemistry at the Faculty of Life Sciences.
Professor Langer has published or authored over 170 original articles, chapters and invited reviews.
His research interests range from medicinal chemistry, including theoretical pharmaceutical chemistry, drug design and pharmacophore modeling, in addition to QSAR and 3D-QSAR molecular modeling techniques.
In 2003 Professor Langer founded Inte:Ligand, a software development and consultancy organization for which he served as CEO until 2008. He was then appointed CEO of Prestwick Chemical, a world renowned contract research organization specializing in medicinal chemistry services. Under his leadership, several drug discovery programs in different fields of applications were successfully advanced into pre-clinical and clinical development stages.
Professor Pujol founded his consulting firm in 2013, and uses his extensive and unique experience both in academic research and in leading international pharmaceutical companies to manage the company.
Notably, Professor Pujol was, Director of Research at INSERM (French National Institute of Health and Medical Research), before becoming Professor of Physiology at the School of Medicine at Lyon University, France and Director of Neuropharmacology Research Laboratories at INSERM and CNRS (French National Centre of Scientific Research). He was also Director of the Central Nervous System Department at the Roussel Uclaf Group Research Center (Sanofi) and director of the Research PET imaging Center in Lyon (CERMEP). He also founded Biocortech, a biotech company working in therapeutics and diagnostics for Central Nervous System, and served as CEO from 2001 to 2012.
Throughout his career, Professor Pujol has published more than 200 scientific articles and registered 21 patents in brain medicinal drug discovery